Pharmaceuticals, Biotechnology and Life Sciences
Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development OXFORD,…
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s”) (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that it has entered…
Spark Therapeutics, Ultragenyx and Others to Headline March 24-26 Meeting in Barcelona BARCELONA, Spain–(BUSINESS WIRE)–#BPSMTeu–With the global market for gene…
LONDON–(BUSINESS WIRE)–Rexgenero, a regenerative medicine company developing advanced cell therapies to treat chronic limb-threatening ischemia (CLI), today announces that Dr…
PXL770, a novel direct AMP kinase activator, observed to reduce liver inflammatory cells, which may contribute to an improvement of…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
NDA is supported by data from the phase 3 ASCERTAIN study of oral C-DEC in adults with intermediate- and high-risk…
— Net income of $1.2 million driven by 6.7% revenue growth from prior year period and 18.3% operating margin —…
Transaction Expected to be Immediately Accretive to Revenues and Adjusted EPS Slides to accompany this announcement are posted to Ligand.com…
SALT LAKE CITY–(BUSINESS WIRE)–PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced…